Roxicodone ( oxycodone Hydrochloride)


Roxicodone ( oxycodone Hydrochloride)


Add to Wishlist
Add to Wishlist


What is Roxicodone ( oxycodone Hydrochloride)?

Roxicodone ( oxycodone Hydrochloride) is an opioid analgesic.

Each tablet for oral administration contains 5 mg, 15 mg or 30 mg of oxycodone hydrochloride USP.

Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).

Chemically, oxycodone hydrochloride is 4, 5α-epoxy-14-hydroxy-3-methoxy-17methylmorphinan-6-one hydrochloride.


ROXICODONE (oxycodone hydrochloride)  tablets are an immediate-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.

DOSAGE AND ADMINISTRATION OF Roxicodone ( oxycodone Hydrochloride)

ROXICODONE (oxycodone hydrochloride)  is intended for the management of moderate to severe pain in patients who require treatment with an oral opioid analgesic. The dose should be individually adjusted according to severity of pain, patient response and patient size. If the pain increases in severity, if analgesia is not adequate, or if tolerance occurs, a gradual increase in dosage may be required.

Patients who have not been receiving opioid analgesics should be started on ROXICODONE (oxycodone hydrochloride) in a dosing range of 5 to 15 mg every 4 to 6 hours as needed for pain. The dose should be titrated based upon the individual patient’s response to their initial dose of ROXICODONE (oxycodone hydrochloride). Patients with chronic pain should have their dosage given on an aroundthe-clock basis to prevent the reoccurrence of pain rather than treating the pain after it has occurred. This dose can then be adjusted to an acceptable level of analgesia taking into account side effects experienced by the patient.

For control of severe chronic pain, ROXICODONE (oxycodone hydrochloride) should be administered on a regularly scheduled basis, every 4-6 hours, at the lowest dosage level that will achieve adequate analgesia.

As with any potent opioid, it is critical to adjust the dosing regimen for each patient individually, taking into account the patient’s prior analgesic treatment experience. Although it is not possible to list every condition that is important to the selection of the initial dose of ROXICODONE (oxycodone hydrochloride), attention should be given to: 1) the daily dose, potency, and characteristics of a pure agonist or mixed agonist/antagonist the patient has been taking previously, 2) the reliability of the relative potency estimate to calculate the dose of oxycodone needed, 3) the degree of opioid tolerance, 4) the general condition and medical status of the patient, and 5) the balance between pain control and adverse experiences.

SIDE EFFECTS OF Roxicodone ( oxycodone Hydrochloride)

Roxicodone ( oxycodone Hydrochloride) tablets have been evaluated in open label clinical trials in patients with cancer and nonmalignant pain. ROXICODONE (oxycodone hydrochloride)  tablets are associated with adverse experiences similar to those seen with other opioids.

Serious adverse reactions that may be associated with ROXICODONE (oxycodone hydrochloride) therapy in clinical use are those observed with other opioid analgesics and include: respiratory depression, respiratory arrest, circulatory depression, cardiac arrest, hypotension, and/or shock (see OVERDOSEWARNINGS).

The less severe adverse events seen on initiation of therapy with ROXICODONE (oxycodone hydrochloride) are also typical opioid side effects. These events are dose dependent, and their frequency depends on the clinical setting, the patient’s level of opioid tolerance, and host factors specific to the individual. They should be expected and managed as a part of opioid analgesia. The most frequent of these include nausea, constipation, vomiting, headache, and pruritus.

In many cases the frequency of adverse events during initiation of opioid therapy may be minimized by careful individualization of starting dosage, slow titration and the avoidance of large rapid swings in plasma concentration of the opioid. Many of these adverse events will abate as therapy is continued and some degree of tolerance is developed, but others may be expected to remain throughout therapy.

In all patients for whom dosing information was available (n=191) from the open-label and double-blind studies involving ROXICODONE (oxycodone hydrochloride) ®, the following adverse events were recorded in ROXICODONE (oxycodone hydrochloride) ® treated patients with an incidence ≥ 3%. In descending order of frequency they were: nausea, constipation, vomiting, headache, pruritus, insomnia, dizziness, asthenia, and somnolence.

The following adverse experiences occurred in less than 3% of patients involved in clinical trials with oxycodone:

Body as a Whole: abdominal pain, accidental injury, allergic reactionback painchills and fever, fever, flu syndrome, infectionneck pain, pain, photosensitivity reaction, and sepsis.

Cardiovascular: deep thrombophlebitisheart failurehemorrhage, hypotension, migraine, palpitation, and tachycardia.

Digestive: anorexiadiarrheadyspepsiadysphagiagingivitisglossitis, and nausea and vomiting.

Hemic and Lymphatic: anemia and leukopenia.

Metabolic and Nutritional: edemagouthyperglycemia, iron deficiency anemia and peripheral edema.

Musculoskeletal: arthralgiaarthritis, bone pain, myalgia and pathological fracture.

Nervous: agitation, anxiety, confusion, dry mouthhypertonia, hypesthesia, nervousness, neuralgiapersonality disordertremor, and vasodilation.

Respiratory: bronchitis, cough increased, dyspneaepistaxis, laryngismus, lung disorder, pharyngitisrhinitis, and sinusitis.


Roxicodone  is metabolized in part to oxymorphone via the cytochrome p450 isoenzyme CYP2D6. While this pathway may be blocked by a variety of drugs (e.g., certain cardiovascular drugs and antidepressants), such blockade has not yet been shown to be of clinical significance with this agent. However, clinicians should be aware of this possible interaction.

Neuromuscular Blocking Agents: Oxycodone, as well as other opioid analgesics, may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.

CNS Depressants: Patients receiving narcotic analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics or other CNS depressants (including alcohol) concomitantly with ROXICODONE (oxycodone hydrochloride) may exhibit an additive CNS depression. Interactive effects resulting in respiratory depression, hypotension, profound sedation, or coma may result if these drugs are taken in combination with the usual dosage of ROXICODONE (oxycodone hydrochloride) . When such combined therapy is contemplated, the dose of one or both agents should be reduced.

Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol and buprenorphine) should be administered with caution to patients who have received or are receiving a course of therapy with a pure opioid agonist analgesic such as ROXICODONE (oxycodone hydrochloride). In this situation, mixed agonist/antagonist analgesics may reduce the analgesic effect of ROXICODONE (oxycodone hydrochloride) and/or may precipitate withdrawal symptoms in these patients.

Monoamine Oxidase Inhibitors (MAOIs): MAOIs have been reported to intensify the effects of at least one opioid drug causing anxiety, confusion and significant depression of respiration or coma. The use of ROXICODONE  is not recommended for patients taking MAOIs or within 14 days of stopping such treatment.

Buy Roxicodone,Order Roxicodone online,Roxicodone Price.

Additional information


Roxycodone 30mg (100 tablets), Roxycodone 30mg (200 tablets), Roxycodone 30mg (350 tablets), Roxycodone 30mg (500 tablets), Roxycodone 30mg (750 tablets), Roxycodone 15mg (125 tablets), Roxycodone 15mg (250 tablets), Roxycodone 15mg (500 tablets), Roxycodone 15mg (700 tablets), Roxycodone 15mg (1000 tablets)


There are no reviews yet.

Be the first to review “Roxicodone ( oxycodone Hydrochloride)”

Your email address will not be published. Required fields are marked *

Close Menu